glp 1 drug coverage How many adults with private health insurance could use GLP-1 drugs McKee's proposed FY2027 budget drops

The mechanism is straightforward: GLP-1 RAs enhance glucose-dependent insulin secretion, and stacking that on top of glucose-independent insulin release from exogenous insulin or sulfonylureas removes the glucose-dependent safety brake

GLP-1 medications are often used when diet, exercise, and other medicines have not provided enough benefit

Nakade, Y., Tsukamoto, K., Iwa, M., Pappas, T

Cardiovascular Safety : The cardiovascular safety of tirzepatide has been evaluated and confirmed to date through a pre-specified meta-analysis of phase 2 and 3 randomized trials comparing tirzepatide with other placebo, insulin glargine, degludec, semaglutide, dulaglutide for a minimum of 26 weeks (including the GPGB, SURPASS 1,2,3,4,5, and J-mono studies) [67]